CVRF
  • Login
  • Register
  • CVRF's Meetings
    TCTAP AP VALVES & SH COMPLEX PCI

SummitMD SummitMD

TCTAP 2023
  • Home
  • News
    • SummitMD News
    • Conference News
      • TCTAP
      • AP VALVES & SH
      • COMPLEX PCI
      • ACT PROGRAM
  • Videos
    • TCTAP
    • AP VALVES & SH
    • COMPLEX PCI
    • ACT PROGRAM
  • Slides
    • Coronary
    • Endovascular
    • Structural Heart Disease
    • Valve
    • Imaging & Physiology
    • Pharmacology
  • Book
  • Conferences
    • TCTAP
    • AP VALVES & STRUCTURAL HEART
    • COMPLEX PCI
  • About CVRF
    • Mission
    • Board Members
    • R&D Divisions
      • Clinical Research Coordinating Center
      • Translational Research Center
      • Research Activity
      • Paper Publication
    • Education
      • ACT Program
      • Website

Slides Pharmacology

  • Home
  • Slides
No Title Presenter Date
96 Potent P2Y12 Inhibitors for East-Asian Patients: Insights from the TWIGHLIGHT in Western vs. Asian Population Roxana Mehran Apr. 12. 21
95 \"Less is More\" in Antithrombotic Therapy After PCI: Clinically Relevant not only in East-Asian but also in Western Population Takeshi Kimura Apr. 12. 21
94 Antithrombotic Therapy in East Asian with ACS/PCI: Updated Evidences for East-Asian Paradox Glenn N. Levine Apr. 12. 21
93 Composite Outcomes and Net Adverse Events: Implications for Trial Design and Interpretation David Joel Cohen Apr. 12. 21
92 Escalation and De-Escalation Strategy for CHIP-PCI Patients: The Temporal Tuning in the TAILORED-CHIP Trial Duk-Woo Park Apr. 12. 21
91 Short DAPT Followed by P2Y12 Monotherapy: New Trend Updates with Clinical Evidences Davide Capodanno Apr. 12. 21
90 Tailored Antithrombotic Strategy for CHIP and HBR Patients - How To Do? Philip M. Urban Apr. 12. 21
89 Evolving Antithrombotic Strategies for Patients with DM and CAD Dominick J. Angiolillo Apr. 12. 21
88 Shorter DAPT vs. Longer DAPT: Whom and How? - Clinician\'s and Trialist\'s Perspective Robert W. Yeh Apr. 12. 21
87 Antithrombotic Strategy in PCI and AF Patients: Updated Strategy Alan C. Yeung Nov. 27. 19
1 2 3 4 5 6 7 8 9 10
Conference Slides
  • TCTAP
  • AP VALVES & SH
  • COMPLEX PCI
Category

Coronary

  • Left Main
  • Bifurcation
  • CTO
  • Long Lesion
  • Ostial
  • In-stent Restenosis
  • Others

Endovascular

  • Carotid
  • Peripheral Disease
    • SFA
    • BTK
    • Iliac
    • Poplitial
    • Subclavian
  • Abdominal Aorta
  • Renal
  • Others

Structural Heart Disease

  • Congenital Heart Disease
  • HOCM
  • Others

Valve

  • TAVR
  • Others

Imaging & Physiology

  • Antiplatelet
  • Anticoagulant
  • Lipid and Inflammation
  • Others

Pharmacology

  • Antiplatelet
  • Anticoagulant
  • Lipid and Inflammation
  • Others

CardioVascular Research Foundation
2F Asan Institute for Education & Research
88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul 05505, Korea
Business Registration Number: 215-82-06387

Privacy Policy

The Latest News
  • Extended BEST trial offers insight into murky dispute over optimal long-term revasc strategy in MVCAD
    23-01-06
  • TAVI noninferior to surgery for elderly, severe AS patients at moderate operative risk: UK TAVI
    22-10-14
  • [DOWNLOAD FREE EBOOK] Technical Forum A to Z: Complex Coronary Intervention - 3rd Edition
    22-10-7
Porto Website Template

Copyright 2002. All Rights Reserved.